Clorox's disinfecting wipes won't be fully available in groceries until next year, with stocks running low due to the six-fold increase in demand, says CEO Benno Dorer.
According to Dorer, other than being the hottest commodity in its product line, disinfecting wipes take longer to produce because of a very complex supply chain.
He noted that wipes are made from polyester spunlace, which are currently in short supply as it is also a material for protective wear like masks and medical gowns.
However, supply for most of Clorox's products, like liquid bleach, will improve dramatically over the next four to six months.
Since the start of global lockdowns, hygiene goods makers have a sustained boom in sales.
The California-based company has a stock shortage across much of its products, such as Burt's Bees lip balm and Glad trash bags.
While Clorox usually holds excess supply for flu seasons, it cannot keep up with overwhelming pandemic-triggered demand for many of its disinfectants.
Dorer said the entire supply chain is stressed and that it would probably take the company until 2021 to meet the demand.


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



